Use the labels in the right column to find what you want. Or you can go thru them one by one, there are only 33,929 posts. Searching is done in the search box in upper left corner. I blog on anything to do with stroke. DO NOT DO ANYTHING SUGGESTED HERE AS I AM NOT MEDICALLY TRAINED, YOUR DOCTOR IS, LISTEN TO THEM. BUT I BET THEY DON'T KNOW HOW TO GET YOU 100% RECOVERED. I DON'T EITHER BUT HAVE PLENTY OF QUESTIONS FOR YOUR DOCTOR TO ANSWER.
Changing stroke rehab and research worldwide now.Time is Brain!trillions and trillions of neuronsthatDIEeach day because there areNOeffective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.
What this blog is for:
My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.
Monday, August 24, 2026
Meet Aletta: The first FDA approved robotic blood draw device
Aletta has been approved in Europe for the past two years. (Vitestro)The FDA has approved Vitestro’s Aletta as the first standalone robotic device in the U.S. designed to draw blood without the need for hands-on human help. The approval, the FDA said in a release, will help plug the gap for the ongoing and major shortage of phlebotomists in the U.S. The robot still requires oversight from a phlebotomist, but one specialist can oversee up to three devices at once, easing pressure on blood draws in an outpatient setting. Aletta performs the entire blood draw on its own, from placing the tourniquet to applying the bandage. To locate a suitable vein, Aletta uses multimodal imaging that combines near-infrared and ultrasound. The device also uses Doppler ultrasound to confirm it has selected a vein and not an artery. In a key trial, the device showed a 94.5% first-stick success rate, with 90% of those in the study seeing pain levels for Aletta that were lower or similar to a manual blood draw. Aletta has been approved in Europe for the past two years. Back in March, the Netherlands-based medtech nabbed $70 million in an oversubscribed series B round backed by investors including Labcorp Venture Fund, Mayo Clinic, and Sutter Health, among others. That cash will be used for manufacturing scale-up, clinical expansion, and commercialization as the company prepares for broader market adoption in Europe and now entry into the U.S. market.“This authorization reflects the FDA’s commitment to advancing innovative medical devices that help meet a critical public health need while maintaining the safety and effectiveness patients deserve,” said Michelle Tarver, M.D., Ph.D. Director of the FDA’s Center for Devices and Radiological Health, in a statement.
“Blood draws are one of the most commonly performed medical procedures in the United States, yet patients may face delays due to a growing shortage of trained phlebotomists.”
No comments:
Post a Comment